Clinical Trial Update: Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cystoscopy with Hexyl 5-aminolevulinate for detecting carcinoma in situ in bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Hexyl 5-aminolevulinate (hexyl 5-aminolevulinate)

Snippet

Sponsor: Photocure | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED